XML 86 R67.htm IDEA: XBRL DOCUMENT

Note 19 - Adoption of U.S. GAAP (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Accounting Standards Update and Change in Accounting Principle [Table Text Block]

		Year Ended December 31, 2021
		IFRS				Adjustments/ Reclassifications			Note		U.S. GAAP
Revenue		$	4,247			$	—				$	4,247
Costs and expenses
Cost of sales			1,876				—					1,876
General administrative expenses			36,649				(9	)	a, c			36,640
Research and development			9,640				(4	)	b			9,636
Depreciation expense			10,825				(97	)	b			10,728
Other operating expenses, net			14,002				—					14,002
Total costs and expenses			72,992				(110	)				72,882
Operating loss			(68,745	)			110					(68,635	)
Other income (expense), net
Finance costs, net			(11,769	)			2,031		c, d			(9,738	)
Change in fair value of financial instruments			(42,102	)			60,085		d			17,983
Gain (loss) on extinguishment of debt			3,576				(40,792	)	d			(37,216	)
Other income (expense), net			1,067				2		c			1,069
Total other income (expense), net			(49,228	)			21,326					(27,902	)
Loss before income tax			(117,973	)			21,436					(96,537	)
Income tax			232				—					232
Net loss available to common stockholders		$	(117,741	)		$	21,436				$	(96,305	)
Other comprehensive loss
Foreign currency translation loss, net of tax			(86	)			—					(86	)
Comprehensive loss		$	(117,827	)		$	21,436				$	(96,391	)

Basic loss for the period attributable to common stockholders		$	(7.07	)		$	1.29		e		$	(5.78	)
Basic weighted-average common shares outstanding			16,655,634				—		e			16,655,634
Diluted loss for the period attributable to common stockholders		$	(7.07	)		$	1.29		e		$	(5.78	)
Diluted weighted-average common shares outstanding			16,655,634				—		e			16,655,634

		Year Ended December 31, 2020
		IFRS				Adjustments/ Reclassifications			Note		U.S. GAAP
Revenue		$	—			$	—				$	—
Costs and expenses
Cost of sales			—				—					—
General administrative expenses			8,127				(124	)	a, c			8,003
Research and development			5,878				46		a, b			5,924
Depreciation expense			3,182				(151	)	b			3,031
Other operating expenses, net			5,476				(27	)	a, b			5,449
Total costs and expenses			22,663				(256	)				22,407
Operating loss			(22,663	)			256					(22,407	)
Other income (expense), net
Finance costs, net			(22	)			57		c, d			35
Change in fair value of financial instruments			(84,224	)			93,861		d			9,637
Gain (loss) on extinguishment of debt			(7,466	)			(1,774	)	d			(9,240	)
Other income (expense), net			597				(3	)	c			594
Total other income (expense), net			(91,115	)			92,141					1,026
Loss before income tax			(113,778	)			92,397					(21,381	)
Income tax			(148	)			—					(148	)
Net loss available to common stockholders		$	(113,926	)		$	92,397				$	(21,529	)
Other comprehensive loss
Foreign currency translation loss, net of tax			—				—					—
Comprehensive loss		$	(113,926	)		$	92,397				$	(21,529	)

Basic loss for the period attributable to common stockholders		$	(7.11	)		$	5.76		e		$	(1.34	)
Basic weighted-average common shares outstanding			16,029,826				—		e			16,029,826
Diluted loss for the period attributable to common stockholders		$	(7.11	)		$	5.76		e		$	(1.34	)
Diluted weighted-average common shares outstanding			16,029,826				—		e			16,029,826

		IFRS				Adjustments / Reclassifications			Note		U.S. GAAP
ASSETS
Current assets
Cash and cash equivalents		$	8,533			$	—				$	8,533
Accounts receivable			1,196				—					1,196
Prepaid expenses and other current assets			2,695				—					2,695
Total current assets			12,424				—					12,424
Property and equipment, net			33,586				(1,056	)	b			32,530
Operating lease right-of-use assets			2,663				292		c			2,955
Deferred income tax assets			1,640				—					1,640
Other non-current assets			369				—					369
Total assets		$	50,682			$	(764	)			$	49,918
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable		$	6,650			$	—				$	6,650
Debt			246,189				(137,716	)	d			108,473
Warrant liabilities			—				143,237		d			143,237
Operating lease liabilities			891				94		c			985
Contract liabilities			935				—					935
Accrued expenses and other liabilities			23,435				—					23,435
Total current liabilities			278,100				5,615					283,715
Operating lease liabilities			1,908				175		c			2,083
Contract liabilities			1,000				—					1,000
Other non-current liabilities			2,552				—					2,552
Total liabilities			283,560				5,790					289,350
Redeemable preferred stock			—				21,306		d			21,306
Stockholders’ equity (deficit)
Treasury stock			(170,949	)			—					(170,949	)
Additional paid-in capital			235,909				(139,438	)	a, d			96,471
Accumulated other comprehensive loss			(86	)			—					(86	)
Accumulated deficit			(297,752	)			111,578					(186,174	)
Total stockholders’ equity (deficit)			(232,878	)			(27,860	)				(260,738	)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)		$	50,682			$	(764	)			$	49,918

		Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)		2021				2020
General and administrative expenses		$	(80	)		$	(136	)
Research and development			—				(89	)
Other operating expenses			—				(27	)
Increase (decrease) to loss before income tax		$	(80	)		$	(252	)

(Consolidated Balance Sheet)		December 31, 2021
Additional paid-in-capital		$	542
Adjustment to accumulated deficit			(542	)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)		$	—

		Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)		2021				2020
Research and development		$	(4	)		$	135
Depreciation expense			(97	)			(151	)
Other operating expenses			—				—
Increase (decrease) to loss before income tax		$	(101	)		$	(16	)

(Consolidated Balance Sheet)		December 31, 2021
Property and equipment, net		$	(1,056	)
Total assets		$	(1,056	)
Adjustment to accumulated deficit		$	(1,056	)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)		$	(1,056	)

		Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)		2021				2020
General and administrative expenses		$	71			$	12
Less: Finance costs, net			(49	)			(57	)
Less: Other income, net			(2	)			3
Increase (decrease) to loss before income tax		$	20			$	(42	)

(Consolidated Balance Sheet)		December 31, 2021
Operating lease right-of-use assets		$	292
Total assets		$	292
Operating lease liabilities		$	94
Non-current operating lease liabilities			175
Adjustment to accumulated deficit			23
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)		$	292

		Year Ended December 31,
(Consolidated Statements of Operations and Comprehensive Loss)		2021				2020
Less: Finance costs, net		$	(1,982	)		$	—
Less: Change in fair value of financial instruments			(60,085	)			(93,861	)
Less: Gain (Loss) on extinguishment of debt			40,792				1,774
Increase (decrease) to loss before income tax		$	(21,275	)		$	(92,087	)

(Consolidated Balance Sheet)		December 31, 2021
Debt		$	(137,716	)
Redeemable Series X preferred stock			21,306
Warrant liability			143,237
Additional paid-in capital			(139,980	)
Adjustment to accumulated deficit			113,153
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)		$	—

		Year Ended December 31,
		2021				2020
Net loss attributable to common stockholders		$	(96,305	)		$	(21,529	)
Basic weighted-average common shares outstanding ⁽¹⁾			16,655,634				16,029,826
Basic loss per share for the period attributable to common stockholders		$	(5.78	)		$	(1.34	)

Dilutive numerator		$	(96,305	)		$	(21,529	)
Diluted weighted-average common shares outstanding			16,655,634				16,029,826
Diluted loss per share for the period attributable to common stockholders		$	(5.78	)		$	(1.34	)